Chief Business Officer
Arnaud is responsible for driving ABL’s business development and commercial strategy. He brings 30 years of experience in the chemical and pharmaceutical industry with a specific focus on CDMO business development and partnership management. Before joining ABL, Arnaud held different positions within Sanofi, including Head of CDMO at the Business Unit dedicated to third party business. He has contributed to the development and implementation of breakthrough industrial platforms in Biologics and entered in creative and innovative partnerships.
Arnaud holds a PhD in Bioorganic Chemistry from Université Pierre et Marie Curie.